Michelle Murray, NP
Family · Charleston, WVNPI 1194143123
Payments from drug & device makers
Across 620 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Boehringer Ingelheim$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Sanofi$1K
- Axsome Therapeutics, Inc.$617
- plus $5K from 28 others
What the payments were for
- Food & beverage$12,61498%
- Education$2012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 83 | $2,102 |
| GSK | 111 | $1,549 |
| Boehringer Ingelheim | 68 | $1,472 |
| Regeneron Healthcare Solutions, Inc. | 52 | $1,367 |
| Sanofi | 45 | $1,104 |
| Axsome Therapeutics, Inc. | 26 | $617 |
| Novartis | 30 | $556 |
| Insmed, Inc. | 29 | $537 |
| Pulmonx Corporation | 12 | $448 |
| Mylan Specialty L.p. | 20 | $398 |
| Verona Pharma, Inc. | 14 | $332 |
| Amgen | 18 | $316 |
| Genentech USA, Inc. | 22 | $248 |
| Harmony Biosciences LLC | 9 | $215 |
| United Therapeutics Corporation | 9 | $209 |
| Jazz Pharmaceuticals Inc. | 10 | $178 |
| Baxter Healthcare | 9 | $175 |
| Sanofi-aventis U.S. LLC | 3 | $158 |
| Electromed, Inc. | 20 | $153 |
| Galvanize Therapeutics, Inc | 1 | $127 |
| Actelion Pharmaceuticals US, Inc. | 4 | $111 |
| Mallinckrodt Hospital Products Inc. | 5 | $108 |
| Advanced Respiratory, Inc | 4 | $69 |
| Eisai Inc. | 3 | $51 |
| La Jolla Pharmaceutical Company | 3 | $50 |
| Merck | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Philips North America LLC | 1 | $15 |
| Inogen, Inc. | 1 | $13 |
| Advanced Oxygen Therapy Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$760
- BREZTRI$535
- SYMBICORT$247
- AIRSUPRA$225
- BEVESPI AEROSPHERE$152
- CHARTIS CATHETER$152
- ZEPHYR DELIVERY CATHETER$152
- ZEPHYR ENDOBRONCHIAL VALVE$152
- PULMONX CHARTIS TABLET CONSOLE$152
- ALIYA SYSTEM$127
How this compares
$12,815 in reported general payments places this provider in the 95th percentile of 1,507 family providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 369 | $336,913 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 108 | $92,766 |
| Spiriva RespimatTiotropium Bromide | 77 | $67,438 |
| Breo ElliptaFluticasone/Vilanterol | 89 | $56,185 |
| SymbicortBudesonide/Formoterol Fumarate | 116 | $41,571 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 52 | $37,993 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 60 | $33,187 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 577 | $27,556 |
| Incruse ElliptaUmeclidinium Bromide | 31 | $20,088 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 81 | $18,840 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 18 | $10,098 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 36 | $8,794 |
| Ventolin HfaAlbuterol Sulfate | 82 | $8,183 |
| BreynaBudesonide/Formoterol Fumarate | 21 | $5,692 |
| Arnuity ElliptaFluticasone Furoate | 15 | $5,671 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $1,549 | $452,044564 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $2,102 | $144,435242 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $1,472 | $105,430129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,507 family providers in West Virginia.
Other family in Charleston
- Ashley ComerCharleston$213K
- Sarah KnightCharleston$99K
- Angela SettleCharleston$51K
- Malea SmithCharleston$13K
- Kara DravenstottCharleston$11K
- Stacy RichardsonCharleston$11K
- Rebecca ButcherCharleston$9K
- Jade LewisCharleston$8K
- Ashton HolbrookCharleston$8K
- Samantha StoneCharleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.